RBM39 is a coactivator of ER, ER, and Activator Protein‐1 (AP‐1) component c‐Jun, which binds transcription and mRNA precursor processing together and effectively boosts their transcriptional activity, hence encouraging breast cancer growth.17 Here, RBM39 is linked to breast carcinoma.